CN106699687B - 一种含硒的kga/gac和/或gdh抑制剂化合物 - Google Patents
一种含硒的kga/gac和/或gdh抑制剂化合物 Download PDFInfo
- Publication number
- CN106699687B CN106699687B CN201510789110.5A CN201510789110A CN106699687B CN 106699687 B CN106699687 B CN 106699687B CN 201510789110 A CN201510789110 A CN 201510789110A CN 106699687 B CN106699687 B CN 106699687B
- Authority
- CN
- China
- Prior art keywords
- compound
- ebselen
- glutaminase
- cancer
- increase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
- C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
Description
Claims (4)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510789110.5A CN106699687B (zh) | 2015-11-17 | 2015-11-17 | 一种含硒的kga/gac和/或gdh抑制剂化合物 |
PCT/CN2016/106202 WO2017084598A1 (en) | 2015-11-17 | 2016-11-17 | Selenium-containing inhibitors that bind to the allosteric site of glutaminase and/or inhibit glutamate dehydrogenase and their applications |
US15/983,079 US10596152B2 (en) | 2015-11-17 | 2018-05-17 | Selenium containing KGA/GDH dual inhibitors and the applications thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510789110.5A CN106699687B (zh) | 2015-11-17 | 2015-11-17 | 一种含硒的kga/gac和/或gdh抑制剂化合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106699687A CN106699687A (zh) | 2017-05-24 |
CN106699687B true CN106699687B (zh) | 2019-11-01 |
Family
ID=58717384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510789110.5A Active CN106699687B (zh) | 2015-11-17 | 2015-11-17 | 一种含硒的kga/gac和/或gdh抑制剂化合物 |
Country Status (3)
Country | Link |
---|---|
US (1) | US10596152B2 (zh) |
CN (1) | CN106699687B (zh) |
WO (1) | WO2017084598A1 (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20200188431A1 (en) | 2017-06-09 | 2020-06-18 | Vib Vzw | Glutamine dehydrogenase inhibitors for use in muscle regeneration |
CN107496444A (zh) * | 2017-08-29 | 2017-12-22 | 深圳大学 | 一种硒掺杂黑磷前药及其制备方法 |
CN109988124B (zh) * | 2017-12-29 | 2024-01-09 | 杭州健昵福生物科技有限公司 | 一种含氧族元素二唑或四氮唑结构的肾型谷氨酰胺酶变构位点的抑制剂 |
CN111138215B (zh) * | 2020-01-17 | 2023-04-25 | 湖南诺维信生物科技有限公司 | 一种培育富硒农产品的营养液 |
US20230167120A1 (en) * | 2020-04-13 | 2023-06-01 | Keaise Medicine Wuhan Corp. | Aryl-fused isoselenazole compound containing tetrazine substituent, synthesis method therefor, and use thereof |
CN113527329A (zh) * | 2020-04-22 | 2021-10-22 | 上海中医药大学附属龙华医院 | 含硒化合物及其医药用途 |
CN115192524B (zh) * | 2021-04-13 | 2023-08-29 | 杭州汉菁生物科技有限公司 | 一种包载链状难溶药物的聚合型胶束及制备方法和应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1990475A (zh) * | 2005-12-29 | 2007-07-04 | 曾慧慧 | 取代苯并异硒唑酮类化合物及其用途 |
CN102234254A (zh) * | 2010-04-23 | 2011-11-09 | 北京大学 | 一种苯并异硒唑类化合物及其制备方法和其应用 |
-
2015
- 2015-11-17 CN CN201510789110.5A patent/CN106699687B/zh active Active
-
2016
- 2016-11-17 WO PCT/CN2016/106202 patent/WO2017084598A1/en active Application Filing
-
2018
- 2018-05-17 US US15/983,079 patent/US10596152B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1990475A (zh) * | 2005-12-29 | 2007-07-04 | 曾慧慧 | 取代苯并异硒唑酮类化合物及其用途 |
CN102234254A (zh) * | 2010-04-23 | 2011-11-09 | 北京大学 | 一种苯并异硒唑类化合物及其制备方法和其应用 |
Non-Patent Citations (3)
Title |
---|
Bisbenzisoselenazol-3(2H)-ones, a New Group of Ebselen Analogues;M. Osajda等;《Polish J. Chem.》;20011231;第75卷;参见第824页图1,第825页表2 * |
Inhibition of thioredoxin reductase by a novel series of bis-1,2-benzisoselenazol-3(2H)-ones: Organoselenium compounds for cancer therapy;Jie He等;《Bioorganic & Medicinal Chemistry》;20120403;第20卷;参见第3817页图1 * |
Novel tacrine–ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity;Fei Mao等;《Bioorganic & Medicinal Chemistry Letters》;20131029;第23卷;参见第6738页图1和第6739页表1 * |
Also Published As
Publication number | Publication date |
---|---|
US20180263961A1 (en) | 2018-09-20 |
US10596152B2 (en) | 2020-03-24 |
CN106699687A (zh) | 2017-05-24 |
WO2017084598A1 (en) | 2017-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106699687B (zh) | 一种含硒的kga/gac和/或gdh抑制剂化合物 | |
Scozzafava et al. | Carbonic anhydrase inhibitors: synthesis of sulfonamides incorporating dtpa tails and of their zinc complexes with powerful topical antiglaucoma properties | |
Kasımoğulları et al. | Synthesis, characterization and antiglaucoma activity of some novel pyrazole derivatives of 5-amino-1, 3, 4-thiadiazole-2-sulfonamide | |
Eldehna et al. | Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies | |
Jin et al. | SAR and molecular mechanism study of novel acylhydrazone compounds targeting HIV-1 CA | |
Daravath et al. | Design, synthesis, spectral characterization, DNA interaction and biological activity studies of copper (II), cobalt (II) and nickel (II) complexes of 6-amino benzothiazole derivatives | |
CN107033087B (zh) | 1h-吲唑-4-胺类化合物及其作为ido抑制剂的用途 | |
Talancon et al. | Diastereomerically pure platinum (II) complexes as antitumoral agents.: The influence of the mode of binding {(N),(N, O)− or (C, N)}− of (1S, 2R)[(η5-C5H5) Fe {(η5-C5H4) CHNCH (Me) CH (OH) C6H5}] and the arrangement of the auxiliary ligands | |
WO2017035982A1 (zh) | 一类邻萘醌化合物、其制备方法和医药用途 | |
CN105061315B (zh) | 一类1,5‑二苯基吡唑‑3‑羧酸类化合物及其应用 | |
Yang et al. | An overview on the synthetic urease inhibitors with structure-activity relationship and molecular docking | |
Ghosh et al. | Dual mode ratiometric recognition of zinc acetate: nanomolar detection with in vitro tracking of endophytic bacteria in rice root tissue | |
US20060264439A1 (en) | Inhibitors of polo-like kinase-1 | |
CN107663182B (zh) | 一种谷氨酰胺代谢抑制剂化合物 | |
Choudhari et al. | Synthesis and biological activity of imidazole based 1, 4-naphthoquinones | |
Peerzada et al. | Identification of morpholine based hydroxylamine analogues: selective inhibitors of MARK4/Par-1d causing cancer cell death through apoptosis | |
CN107200734A (zh) | 奎宁环衍生物及其制备方法和用途 | |
Singh et al. | Synthesis, spectral, thermal and structural characterization of a hexanuclear copper (I) cluster and a cobalt (III) complex of 1-ethyl-3-phenyl-thiourea | |
US8586625B2 (en) | Derivatives of taxol and closely related compounds | |
Wang et al. | Design, synthesis and biological evaluation of some novel thiazole-2-carboxamide derivatives as antitumor agents | |
Dişli et al. | Synthesis of some new 5-substituted 1 H-tetrazoles | |
Chen et al. | Enhanced anti-cancer efficacy to cancer cells by a novel monofunctional mononuclear platinum (ii) complex containing a mixed S, N, S-donor ligand | |
Marc et al. | Rational Synthesis of Some New para-Aminobenzoic Acid Hybrids with Thiazolidin-2, 4-diones with Antimicrobial Properties | |
JP4965428B2 (ja) | セミカルバジド誘導体を含むフリーラジカル消去剤 | |
KR102304622B1 (ko) | 신규한 구조를 갖는 화합물, 이를 포함하는 착물, 항암용 약학 조성물 및 항암제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201124 Address after: 310000 3rd floor, building 13, Fuchun Park, Zhigu, China, Yinhu street, Fuyang District, Hangzhou City, Zhejiang Province Patentee after: Hangzhou Hanjing Biotechnology Co., Ltd Address before: Hangzhou City, Zhejiang province 310014 City Ring Road No. 2, room 347 a tsuchiyama Patentee before: HANGZHOU GAMMA BIOTECH Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210709 Address after: Room 547, No.2, Tushan 1st lane, Huancheng East Road, Shangcheng District, Hangzhou, Zhejiang 310000 Patentee after: HANGZHOU JENNIFER BIOTECH Co.,Ltd. Address before: 310000 3rd floor, building 13, Fuchun Park, Zhongguo Zhigu, Yinhu street, Fuyang District, Hangzhou City, Zhejiang Province Patentee before: Hangzhou Hanjing Biotechnology Co., Ltd |
|
TR01 | Transfer of patent right |